Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2000 1
2004 1
2009 4
2010 2
2011 2
2012 6
2013 4
2014 8
2015 10
2016 15
2017 20
2018 20
2019 25
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M, Martin CL, Miller DT. Kalia SS, et al. Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17. Genet Med. 2017. PMID: 27854360
The updated secondary findings minimum list includes 59 medically actionable genes recommended for return in clinical genomic sequencing. We discuss future areas of focus, encourage continued input from the medical community, and call for research on the impa …
The updated secondary findings minimum list includes 59 medically actionable genes recommended for return in clinical genomic
Medulloblastoma in the age of molecular subgroups: a review.
Juraschka K, Taylor MD. Juraschka K, et al. J Neurosurg Pediatr. 2019 Oct 1;24(4):353-363. doi: 10.3171/2019.5.PEDS18381. J Neurosurg Pediatr. 2019. PMID: 31574483 Review.
In this review, the history of discovery in medulloblastoma is discussed, setting a foundation to outline the current state of understanding of the molecular underpinnings of this disease, with a focus on genomic events that define the aforementioned subgroups and evolving …
In this review, the history of discovery in medulloblastoma is discussed, setting a foundation to outline the current state of understanding …
Implementing genomic medicine in the clinic: the future is here.
Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, Bick D, Bottinger EP, Brilliant MH, Eng C, Frazer KA, Korf B, Ledbetter DH, Lupski JR, Marsh C, Mrazek D, Murray MF, O'Donnell PH, Rader DJ, Relling MV, Shuldiner AR, Valle D, Weinshilboum R, Green ED, Ginsburg GS. Manolio TA, et al. Genet Med. 2013 Apr;15(4):258-67. doi: 10.1038/gim.2012.157. Epub 2013 Jan 10. Genet Med. 2013. PMID: 23306799 Free PMC article. Review.
Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. ...Multiple institutions are actively e …
Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks a …
Future cancer research priorities in the USA: a Lancet Oncology Commission.
Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. Jaffee EM, et al. Lancet Oncol. 2017 Nov;18(11):e653-e706. doi: 10.1016/S1470-2045(17)30698-8. Epub 2017 Oct 31. Lancet Oncol. 2017. PMID: 29208398 Free PMC article. Review.
Enactment of the Cancer Moonshot within the 21st Century Cures Act in the USA arrived at a propitious moment in the advancement of knowledge, providing nearly US$2 billion of funding for cancer research and precision medicine. ...The US National Cancer Institute is already …
Enactment of the Cancer Moonshot within the 21st Century Cures Act in the USA arrived at a propitious moment in the advancement of knowledge …
Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review.
Fatkin D, Huttner IG, Kovacic JC, Seidman JG, Seidman CE. Fatkin D, et al. J Am Coll Cardiol. 2019 Dec 10;74(23):2921-2938. doi: 10.1016/j.jacc.2019.10.011. J Am Coll Cardiol. 2019. PMID: 31806137 Review.
Precision medicine promises to dramatically improve patient outcomes and reduce health care costs through a shift in focus from disease treatment to prevention and individualized therapies. ...Here the authors focus on genetics of dilated cardiomyopathy and provide …
Precision medicine promises to dramatically improve patient outcomes and reduce health care costs through a shift in focus fro …
Implementing precision cancer medicine in the genomic era.
Chen HZ, Bonneville R, Roychowdhury S. Chen HZ, et al. Semin Cancer Biol. 2019 Apr;55:16-27. doi: 10.1016/j.semcancer.2018.05.009. Epub 2018 May 30. Semin Cancer Biol. 2019. PMID: 29857039 Review.
In this review, we will discuss different facets of utilizing genomic data to direct the increasingly complex care of cancer patients. ...Finally, we present an overview of the growing number of genomics-driven clinical trials and conclude with a discussion o …
In this review, we will discuss different facets of utilizing genomic data to direct the increasingly complex care of cancer p …
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, Chowell D, Coussens LM, De Carvalho DD, DeNardo DG, Galon J, Kaufman HL, Kirchhoff T, Lotze MT, Luke JJ, Minn AJ, Politi K, Shultz LD, Simon R, Thórsson V, Weidhaas JB, Ascierto ML, Ascierto PA, Barnes JM, Barsan V, Bommareddy PK, Bot A, Church SE, Ciliberto G, De Maria A, Draganov D, Ho WS, McGee HM, Monette A, Murphy JF, Nisticò P, Park W, Patel M, Quigley M, Radvanyi L, Raftopoulos H, Rudqvist NP, Snyder A, Sweis RF, Valpione S, Zappasodi R, Butterfield LH, Disis ML, Fox BA, Cesano A, Marincola FM; Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups. Bedognetti D, et al. J Immunother Cancer. 2019 May 22;7(1):131. doi: 10.1186/s40425-019-0602-4. J Immunother Cancer. 2019. PMID: 31113486 Free PMC article. Review.
In this event, five working groups aimed at defining a path to test hypotheses according to their relevance to human cancer and identifying experimental models closest to human biology, which include: 1) Germline-Genetic, 2) Somatic-Genetic and 3) Genomic-Transcriptional c …
In this event, five working groups aimed at defining a path to test hypotheses according to their relevance to human cancer and identifying …
Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives.
Ho-Shui-Ling A, Bolander J, Rustom LE, Johnson AW, Luyten FP, Picart C. Ho-Shui-Ling A, et al. Biomaterials. 2018 Oct;180:143-162. doi: 10.1016/j.biomaterials.2018.07.017. Epub 2018 Jul 11. Biomaterials. 2018. PMID: 30036727 Free PMC article. Review.
Here, we focus on what is already implemented in the clinics, what is currently in clinical trials, and what has been tested in animal models. ...
Here, we focus on what is already implemented in the clinics, what is currently in clinical trials, and what has been t …
Gender-specific medicine in the genomic era.
Legato MJ. Legato MJ. Clin Sci (Lond). 2016 Jan;130(1):1-7. doi: 10.1042/CS20150551. Clin Sci (Lond). 2016. PMID: 26586840 Review.
This article is intended to illuminate several important changes in our concept of gender-specific medicine in the genomic era. ...More accurate, rapid and cheaper methods of editing genomic composition are implementing a more sophisticated understandi …
This article is intended to illuminate several important changes in our concept of gender-specific medicine in the genomic era …
Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio.
Manolio TA. Manolio TA. Atherosclerosis. 2016 Oct;253:225-236. doi: 10.1016/j.atherosclerosis.2016.08.034. Epub 2016 Aug 26. Atherosclerosis. 2016. PMID: 27612677 Free PMC article. Review.
As defined by the National Human Genome Research Institute (NHGRI), genomic medicine uses an individual's genetic information in his or her clinical care, and has begun to be applied effectively in areas such as cancer genomics, pharmacogenomics …
As defined by the National Human Genome Research Institute (NHGRI), genomic medicine uses an individual's genetic infor …
118 results
Jump to page
Feedback